Birth · Newborn
Neonatal Sepsis Calculator (EOS)
Early-onset sepsis (EOS) risk-based calculator — simplified educational implementation of the Kaiser Permanente / Kuzniewicz 2017 model. Reduces unnecessary antibiotic exposure by 60-70 % vs categorical risk-factor algorithms.
Last reviewed 25 May 2026
Neonatal sepsis risk per 1,000 live births
GBS status
Intrapartum antibiotics
Clinical exam at evaluation
Introduction
Early-onset neonatal sepsis (EOS) is bacterial bloodstream infection presenting in the first 72 hours of life. Incidence is ~0.5 per 1,000 live births in well-resourced settings (down from ~3 per 1,000 before universal GBS prophylaxis). Despite low incidence, mortality remains 5-15 %, motivating careful identification and prompt treatment of at-risk newborns.
The Kaiser Permanente Neonatal Sepsis Calculator (Kuzniewicz 2017) is a quantitative risk-based tool that integrates maternal intrapartum factors and newborn clinical exam to estimate EOS probability per 1,000 live births. AAP 2018/2019 endorses risk-based approaches for late-preterm and term neonates.
The model inputs
- Gestational age — baseline EOS rate varies (~0.7 per 1,000 at 34 weeks, ~0.13 at 41 weeks).
- Maternal maximum intrapartum temperature — the strongest single predictor; temperatures ≥ 38.0 °C raise risk 3-12× depending on peak.
- GBS status and intrapartum antibiotics — GBS positive without adequate antibiotics raises risk 8×; with adequate prophylaxis only 2×.
- Duration of ruptured membranes — longer ROM increases ascending infection risk.
- Newborn clinical exam — the strongest single MODIFIABLE input. Well-appearing = LR 0.41; equivocal = LR 5; clinically ill = LR 21.
The output tiers
- < 0.5/1,000 — Routine well-baby care. No additional surveillance.
- 0.5-1.0/1,000 — Enhanced observation. Vital signs q4h × 24h. Empirical antibiotics only if deterioration.
- 1.0-3.0/1,000 — Blood culture + close observation. Vital signs q2-4h × 36-48h. Empirical antibiotics considered.
- ≥ 3.0/1,000 — Empirical antibiotics. Septic workup (blood culture, FBC, CRP). Empirical IV ampicillin + gentamicin. NICU consultation.
Why risk-based outperforms categorical
Before 2015, US guidance gave empirical antibiotics for any of: maternal fever, prolonged ROM, GBS positive without adequate prophylaxis, or prematurity. This treated ~7-10 % of all newborns — approximately 400,000 US babies per year — most without sepsis. The Kaiser risk-based approach safely reduces this exposure by 60-70 % without increasing sepsis incidence (Kuzniewicz 2017; Achten 2019).
What “adequate intrapartum antibiotics” means
- Penicillin G, ampicillin, or cefazolin.
- Administered ≥ 4 hours before delivery.
- Clindamycin and vancomycin do NOT count as adequate for GBS prophylaxis.
Limitations
- Validated for ≥ 34 weeks GA. Preterm sepsis evaluation follows separate intensified pathways.
- Does not directly assess for non-GBS pathogens (E. coli, Listeria, viral) or late-onset sepsis (after 72 hours).
- Educational version uses simplified categorical LRs; the original Kaiser calculator uses logistic regression coefficients.
- Clinical judgement supersedes calculator output. A normal calculator result in a clinically ill baby still warrants empirical antibiotics; an abnormal result in a well-appearing baby on observation may not need them.
Sources
- Kuzniewicz MW, et al. A Quantitative, Risk-Based Approach to the Management of Neonatal Early-Onset Sepsis. JAMA Pediatr 2017;171:365-71.
- Puopolo KM, Lynfield R, Cummings JJ; AAP Committee on Fetus and Newborn. Management of Infants at Risk for Group B Streptococcal Disease. Pediatrics 2019;144:e20191881.
- AAP. Management of Neonates Born at ≥35 0/7 Weeks’ Gestation With Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics 2018;142:e20182894.
- Achten NB, et al. Association of Use of the Neonatal Early-Onset Sepsis Calculator With Reduction in Antibiotic Therapy and Safety: A Systematic Review and Meta-analysis. JAMA Pediatr 2019;173:1032-40.
- CDC. Prevention of Perinatal Group B Streptococcal Disease. MMWR 2010 (foundational).